SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Cardinal Health Analysts Raise Price Targets Ahead of Earnings

Several analysts raised their price targets for Cardinal Health in recent weeks. The company is scheduled to report quarterly earnings Thursday; analysts expect EPS of $2.94 and revenue of $66.51 billion.

CAH

Cardinal Health, Inc. (NYSE: CAH ) will release its first quarter earnings report before the opening bell on Thursday, Nov. 5. Analysts expect the Dublin, Ohio-based company to report quarterly earnings of $2.94 per share, up from $2.55 per share in the year-ago period.

The consensus estimate for CAH’s quarterly revenue is $66.51 billion. It reported $64.01 billion last year, according to Pro. On Oct. 1, Cardinal Health reaffirmed its FY27 adjusted EPS guidance above estimates.

Shares of Cardinal Health gained 3.6% to close at $261.93 on Wednesday. readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables. Let’s have a look at how most-accurate analysts have rated the company in the recent period.

Morgan Stanley analyst Erin Wright maintained an Overweight rating and raised the price target from $265 to $286 on Oct. 30, 2026. This analyst has an accuracy rate of 69%. Mizuho analyst Steven Valiquette maintained an Outperform rating and boosted the price target from $250 to $280 on Oct.

20, 2026. This analyst has an accuracy rate of 59%. USB analyst Kevin Caliendo maintained the stock with a Buy rating and raised the price target from $280 to $295 on Oct. 16, 2026.

This analyst has an accuracy rate of 70%. RBC Capital analyst Ryan Halsted initiated coverage on the stock with an Outperform rating and a price target of $276 on Aug. 19, 2026. This analyst has an accuracy rate of 64%.

TD Cowen analyst Charles Rhyee maintained a Buy rating and raised the price target from $275 to $280 on Aug. 13, 2026. This analyst has an accuracy rate of 69%. Considering buying CAH stock?

Here’s what analysts think: Photo via Shutterstock

Related stories